Home > Boards > US Listed > Medical - Drugs > Questcor Pharmaceuticals, Inc. (QCOR)

Questcor Pharmaceuticals, Inc. [$QCOR] due diligence

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
stocktrademan Member Profile
 
Followed By 476
Posts 10,165
Boards Moderated 1
Alias Born 04/28/14
160x600 placeholder
stocktrademan   Wednesday, 07/02/14 10:22:44 AM
Re: None
Post # of 407 
Questcor Pharmaceuticals, Inc. [$QCOR] due diligence

bullish short squeeze

$QCOR

DD Notes ~ http://www.ddnotesmaker.com/QCOR

##### recent news/filings ~ source: finance.yahoo.com

Mon, 30 Jun 2014 22:07:14 GMT ~ Questcor And Mallinckrodt: The Good, The Bad, And The Ugly
read full: http://seekingalpha.com/article/2293805-questcor-and-mallinckrodt-the-good-the-bad-and-the-ugly?source=yahoo
*********************************************************

Mon, 30 Jun 2014 15:53:00 GMT ~ Hey Mallinckrodt, Pay Close Attention - UnitedHealth Just Slammed Questcor's Acthar
read full: http://seekingalpha.com/article/2292885-hey-mallinckrodt-pay-close-attention-unitedhealth-just-slammed-questcors-acthar?source=yahoo
*********************************************************

Thu, 26 Jun 2014 21:47:01 GMT ~ Why Small-Cap Stocks ARRIS and Questcor Have Huge Growth Potential
read full: http://www.fool.com/investing/general/2014/06/26/why-small-cap-stocks-arris-and-questcor-have-huge.aspx?source=eogyholnk0000001
*********************************************************

Wed, 25 Jun 2014 17:49:25 GMT ~ The FDA Owes Us An Answer On Questcor's Acthar
read full: http://seekingalpha.com/article/2286053-the-fda-owes-us-an-answer-on-questcors-acthar?source=yahoo
*********************************************************

Mon, 23 Jun 2014 13:00:00 GMT ~ Questcor Pharmaceuticals Closes Transaction to Acquire International Rights to Synacthen® and Synacthen® Depot
[PR Newswire] - ANAHEIM, Calif., June 23, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (QCOR) today announced that the transaction acquiring rights to Synacthen® and Synacthen® Depot from Novartis Pharma AG and Novartis AG in certain countries outside the U.S. has now closed. Available in more than forty countries for multiple indications, Synacthen (tetracosactide) is a synthetic 24 amino acid melanocortin peptide. Synacthen Depot is a depot formulation of Synacthen. The products are approved outside the U.S. for multiple indications, including certain autoimmune and inflammatory conditions as well as for diagnostic use, but have never been developed or approved for patients in the U.S. Questcor is presently engaged in pre-clinical development for Synacthen in the U.S. "As a leader in melanocortin peptide therapeutics, we now have the opportunity with Synacthen to expand our commercial presence to more than forty international markets, and develop a new potential platform for international growth in this important emerging field of medicine," said Steve Cartt, Chief Operating Officer of Questcor.
read full: http://finance.yahoo.com/news/questcor-pharmaceuticals-closes-transaction-acquire-130000695.html
*********************************************************

##### chart ~ source: stockcharts.com



##### chart ~ source: eoddata.com



##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/QCOR/company-info
Ticker: $QCOR
OTC Market Place: Not Available
CIK code: 0000891288
Company name: Questcor Pharmaceuticals, Inc.
Company website: http://www.questcor.com
Incorporated In: CA, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000891288&owner=exclude&count=40
Latest filings: http://www.otcmarkets.com/stock/QCOR/filings
Latest financials: http://www.otcmarkets.com/stock/QCOR/financials
Latest news: http://www.otcmarkets.com/stock/QCOR/news - http://finance.yahoo.com/q/h?s=QCOR+Headlines

Major holdings: http://data.cnbc.com/quotes/QCOR/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=QCOR+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/QCOR.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=QCOR

RegSho: http://www.regsho.com/tools/symbol_stats.php?sym=QCOR&search=search

DTCC: http://search2.dtcc.com/?q=Questcor+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Questcor+Pharmaceuticals%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results?term=Questcor+Pharmaceuticals%2C+Inc.&x=0&y=0
WHOIS: http://whois.domaintools.com/http://www.questcor.com
Alexa: http://www.alexa.com/siteinfo/http://www.questcor.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.questcor.com

Short Sales: http://www.otcmarkets.com/stock/QCOR/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/QCOR/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/QCOR/research
Historical Prices: http://finance.yahoo.com/q/hp?s=QCOR+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=QCOR+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=QCOR+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=QCOR+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=QCOR+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=QCOR+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=QCOR
Balance Sheet: http://finance.yahoo.com/q/bs?s=QCOR
Cash Flow: http://finance.yahoo.com/q/cf?s=QCOR+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/QCOR
Bloomberg: http://www.bloomberg.com/quote/QCOR:US
Morningstar: http://quotes.morningstar.com/stock/s?t=QCOR
Bussinessweek: http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=QCOR
Barchart: http://www.barchart.com/quotes/stocks/QCOR
OTC Short Report: http://otcshortreport.com/index.php?index=QCOR
Investopedia: http://www.investopedia.com/markets/stocks/QCOR/?wa=0

http://www.pennystocktweets.com/stocks/profile/QCOR

##### last known share structure ~ source: otcmarkets.com

Market Value: $5,639,764,117 a/o
Shares Outstanding: 60,977,015 a/o Mar 31, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value

##### business description ~ source: otcmarkets.com



DD Notes ~ http://www.ddnotesmaker.com/QCOR



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences